Shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) have received an average rating of “Hold” from the six research firms that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $17.08.
A number of brokerages have commented on MD. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Truist Financial boosted their price target on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, February 21st. UBS Group boosted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Mizuho boosted their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 19th. Finally, Macquarie initiated coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target on the stock.
View Our Latest Report on Pediatrix Medical Group
Pediatrix Medical Group Price Performance
Pediatrix Medical Group (NYSE:MD – Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, research analysts anticipate that Pediatrix Medical Group will post 1.38 earnings per share for the current year.
Institutional Trading of Pediatrix Medical Group
A number of hedge funds have recently bought and sold shares of the company. State Street Corp increased its holdings in Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after buying an additional 50,597 shares during the last quarter. Nordea Investment Management AB lifted its position in Pediatrix Medical Group by 51.6% in the fourth quarter. Nordea Investment Management AB now owns 263,633 shares of the company’s stock worth $3,504,000 after purchasing an additional 89,739 shares during the period. Barclays PLC lifted its position in Pediatrix Medical Group by 302.9% in the third quarter. Barclays PLC now owns 142,087 shares of the company’s stock worth $1,646,000 after purchasing an additional 106,817 shares during the period. Franklin Resources Inc. bought a new position in Pediatrix Medical Group in the third quarter worth $598,000. Finally, Principal Financial Group Inc. lifted its position in Pediatrix Medical Group by 14.1% in the third quarter. Principal Financial Group Inc. now owns 513,618 shares of the company’s stock worth $5,953,000 after purchasing an additional 63,581 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Read More
- Five stocks we like better than Pediatrix Medical Group
- How to Use the MarketBeat Stock Screener
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is the Dogs of the Dow Strategy? Overview and Examples
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Invest in Insurance Companies: A Guide
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.